Envestnet Asset Management Inc Agios Pharmaceuticals, Inc. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q4 2024

A detailed history of Envestnet Asset Management Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 24,805 shares of AGIO stock, worth $833,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,805

Previous 24,010 3.31%

Holding current value

$833,696

Previous $1.07 Million 23.55%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$32.86 - $61.64 $26,123 - $49,003	795 Added 3.31%	24,805 $815,000
Q3 2024 Nov 06, 2024	SELL	$41.19 - $49.72 $21,459 - $25,904	-521 Reduced 2.12%	24,010 $1.07 Million
Q2 2024 Aug 08, 2024	BUY	$27.55 - $48.83 $3,140 - $5,566	114 Added 0.47%	24,531 $1.06 Million
Q1 2024 May 13, 2024	BUY	$21.32 - $34.81 $176,998 - $288,992	8,302 Added 51.52%	24,417 $713,000
Q4 2023 Feb 13, 2024	SELL	$19.97 - $24.53 $58,851 - $72,289	-2,947 Reduced 15.46%	16,115 $358,000
Q3 2023 Nov 13, 2023	BUY	$24.36 - $28.18 $32,009 - $37,028	1,314 Added 7.4%	19,062 $471,000
Q2 2023 Aug 04, 2023	BUY	$21.38 - $29.19 $42,760 - $58,380	2,000 Added 12.7%	17,748 $502,000
Q1 2023 May 11, 2023	BUY	$21.74 - $30.93 $20,718 - $29,476	953 Added 6.44%	15,748 $361,000
Q4 2022 Feb 07, 2023	BUY	$24.81 - $31.52 $6,897 - $8,762	278 Added 1.91%	14,795 $415,000
Q3 2022 Nov 10, 2022	BUY	$19.51 - $34.14 $76,518 - $133,897	3,922 Added 37.02%	14,517 $411,000
Q2 2022 Aug 03, 2022	BUY	$17.06 - $31.42 $46,062 - $84,834	2,700 Added 34.2%	10,595 $235,000
Q1 2022 May 04, 2022	BUY	$26.68 - $34.81 $210,638 - $274,824	7,895 New	7,895 $230,000
Q4 2021 Feb 04, 2022	SELL	$29.58 - $49.78 $135,269 - $227,643	-4,573 Closed	0 $0
Q3 2021 Oct 07, 2021	SELL	$41.92 - $58.18 $65,940 - $91,517	-1,573 Reduced 25.59%	4,573 $211,000
Q2 2021 Aug 04, 2021	BUY	$52.06 - $61.27 $112,293 - $132,159	2,157 Added 54.07%	6,146 $339,000
Q1 2021 May 04, 2021	BUY	$44.23 - $57.5 $176,433 - $229,367	3,989 New	3,989 $206,000
Q3 2020 Oct 09, 2020	SELL	$33.87 - $55.93 $150,416 - $248,385	-4,441 Closed	0 $0
Q2 2020 Jul 08, 2020	BUY	$34.45 - $53.48 $152,992 - $237,504	4,441 New	4,441 $238,000
Q1 2020 Apr 23, 2020	SELL	$31.52 - $53.81 $161,035 - $274,915	-5,109 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$30.08 - $50.59 $153,678 - $258,464	5,109 New	5,109 $244,000
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $19,780 - $25,378	-276 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$73.22 - $99.55 $1,025 - $1,393	14 Added 5.34%	276 $23,000
Q1 2018 May 09, 2018	BUY	$59.83 - $86.53 $2,991 - $4,326	50 Added 23.58%	262 $21,000
Q4 2017 Feb 20, 2018	BUY	$52.12 - $72.33 $1,407 - $1,952	27 Added 14.59%	212 $12,000
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $3,567 - $4,362	65 Added 54.17%	185 $12,000
Q2 2017 Aug 14, 2017	BUY	N/A	120	120 $6,000

Others Institutions Holding AGIO

# of Institutions

244

Shares Held

59.9M

Call Options Held

270K

Put Options Held

332K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.84B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Agios Pharmaceuticals, Inc. Transaction History